CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

David Huen, S A Henderson, Debbie Croom-Carter et al. · PubMed · 1995 · 463 citations

Life Sciences, Immunology, Molecular Biology +6

Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score

Philip Went, Claudio Agostinelli, Andrea Gallamini et al. · Journal of Clinical Oncology · 2006 · 386 citations · Full text

Medicine, Oncology, Pathology +17

Programmed mitophagy is essential for the glycolytic switch during cell differentiation

Lorena Esteban‐Martínez, Elena Sierra‐Filardi, Rebecca McGreal et al. · The EMBO Journal · 2017 · 331 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

Sarah Park, Jeeyun Lee, Young Hyeh Ko et al. · Blood · 2007 · 328 citations

Medicine, Infectious Diseases, Oncology +11

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines

HJ Gruss, Norman Boiani, DE Williams et al. · Blood · 1994 · 305 citations · Full text

Medicine, Cell Biology, Oncology +10